MUTATIONS IN OPA1 EXPAND THE CLINICAL PHENOTYPE OF MITOCHONDRIAL DISEASE

被引：0
|
作者：
Chinnery, P. [1 ,2 ,3 ]
Jackson, M. [1 ,2 ,3 ]
Amati-Bonneau, P. [1 ,2 ,3 ]
Yu-Wai-Man, P. [1 ,2 ,3 ]
Gorman, G. [1 ,2 ,3 ]
Duffey, P. [1 ,2 ,3 ]
Baker, M. [1 ,2 ,3 ]
Zeviani, M. [1 ,2 ,3 ]
Horvath, R. [1 ,2 ,3 ]
Miller, J. [1 ,2 ,3 ]
机构：
[1] Newcastle Univ, York Hosp, Newcastle Hosp NHS Trust, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Carlo Besta, Milan, Italy
[3] Univ Angers, Angers, France
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2010年 / 81卷 / 11期
关键词：
D O I：
10.1136/jnnp.2010.226340.62
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E32 / E33
页数：8
相关论文
共 50 条
  • [41] Mitochondrial retention of Opa1 is required for mouse embryogenesis
    Billie A. Moore
    Gladys D. Gonzalez Aviles
    Christine E. Larkins
    Michael J. Hillman
    Tamara Caspary
    Mammalian Genome, 2010, 21 : 350 - 360
  • [42] OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion
    Zanna, Claudia
    Ghelli, Anna
    Porcelli, Anna Maria
    Karbowski, Mariusz
    Youle, Richard J.
    Schimpf, Simone
    Wissinger, Bernd
    Pinti, Marcello
    Cossarizza, Andrea
    Vidoni, Sara
    Valentino, Maria Lucia
    Rugolo, Michela
    Carelli, Valerio
    BRAIN, 2008, 131 : 352 - 367
  • [43] Metabolomics hallmarks OPA1 variants correlating with their in vitro phenotype and predicting clinical severity
    de la Barca, Juan Manuel Chao
    Fogazza, Mario
    Rugolo, Michela
    Chupin, Stephanie
    Del Dotto, Valentina
    Ghelli, Anna Maria
    Carelli, Valerio
    Simard, Gilles
    Procaccio, Vincent
    Bonneau, Dominique
    Lenaers, Guy
    Reynier, Pascal
    Zanna, Claudia
    HUMAN MOLECULAR GENETICS, 2020, 29 (08) : 1319 - 1329
  • [44] OPA1 requires mitofusin 1 to promote mitochondrial fusion
    Cipolat, S
    de Brito, OM
    Dal Zilio, B
    Scorrano, L
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (45) : 15927 - 15932
  • [45] Pathogenicity evaluation and the genotype–phenotype analysis of OPA1 variants
    Xingyu Xu
    Panfeng Wang
    Xiaoyun Jia
    Wenmin Sun
    Shiqiang Li
    Xueshan Xiao
    J. Fielding Hejtmancik
    Qingjiong Zhang
    Molecular Genetics and Genomics, 2021, 296 : 845 - 862
  • [46] Mitochondrial Function: OMA1 and OPA1, the Grandmasters of Mitochondrial Health
    McBride, Heidi
    Soubannier, Vincent
    CURRENT BIOLOGY, 2010, 20 (06) : R274 - R276
  • [47] Optic atrophy plus phenotype due to mutations in the OPA1 gene: Two more Italian families
    Ranieri, Michela
    Del Bo, Roberto
    Bordoni, Andreina
    Ronchi, Dario
    Colombo, Irene
    Riboldi, Giulietta
    Cosi, Alessandra
    Servida, Maura
    Magri, Francesca
    Moggio, Maurizio
    Bresolin, Nereo
    Comi, Giacomo P.
    Corti, Stefania
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 315 (1-2) : 146 - 149
  • [48] The Balance of MFN2 and OPA1 in Mitochondrial Dynamics, Cellular Homeostasis, and Disease
    Zanfardino, Paola
    Amati, Alessandro
    Perrone, Mirko
    Petruzzella, Vittoria
    BIOMOLECULES, 2025, 15 (03)
  • [49] A COMPREHENSIVE SURVEY OF MUTATIONS IN THE OPA1 GENE IN PATIENTS WITH AUTOSOMAL DOMINANT OPTIC ATROPHY 'PLUS' PHENOTYPE
    Ham, M.
    Smith, M.
    Osann, K.
    Kimonis, V
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (01) : 173 - 173
  • [50] OPA1 disease-causing mutants perturb mitochondrial nucleoid cluster distribution
    Eisner, Veronica
    Macuada, Josefa
    Vidal, Gonzalo
    Molina-Riquelme, Isidora
    Aedo, Geraldine
    Lagos, Daniel
    Perez, Nicolas
    Rudge, Timothy
    Cartes-Saavedra, Benjamin
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2022, 1863 : 84 - 85
12345